HUMAN MILK–BASED FORTIFIERS IN PRETERM INFANTS – CLINICAL BENEFITS AND LIMITATIONS IN THE LIGHT OF CURRENT EVIDENCE

Julia Agnieszka Dębczak; Agnieszka Krajewska; Agnieszka Korzeniewska; Natalia Malicka; Katarzyna Tłustochowicz; Karolina Łuczak; Magdalena Korba; Wiktoria Polkowska; Adrianna Kowalik

doi:10.31435/ijitss.2(50).2026.5313

Authors

Julia Agnieszka Dębczak Military Medical Institute – National Research Institute, Warsaw, Poland https://orcid.org/0009-0004-4574-8466
Agnieszka Krajewska Maria Skłodowska-Curie Voivodeship Specialist Hospital in Zgierz, Zgierz, Poland https://orcid.org/0009-0003-2961-7565
Agnieszka Korzeniewska Military Medical Institute – National Research Institute, Warsaw, Poland https://orcid.org/0009-0006-0337-961X
Natalia Malicka Independent Public Healthcare Centre of the Ministry of the Interior and Administration in Kielce, Kielce, Poland https://orcid.org/0009-0002-3045-2908
Katarzyna Tłustochowicz Independent Public Healthcare Centre of the Ministry of the Interior and Administration in Kielce, Kielce, Poland https://orcid.org/0009-0006-4209-2558
Karolina Łuczak Miedzyleski Specialist Hospital in Warsaw, Warsaw, Poland https://orcid.org/0009-0000-5952-8457
Magdalena Korba St. Anne’s Hospital in Miechow, Miechów, Poland https://orcid.org/0009-0002-5577-9923
Wiktoria Polkowska Central Clinical Hospital of the Medical University of Łodz, Łódź, Poland https://orcid.org/0009-0006-3812-9573
Adrianna Kowalik Independent Public Healthcare Complex in Płonsk, Płońsk, Poland https://orcid.org/0009-0001-4092-5839

DOI:

https://doi.org/10.31435/ijitss.2(50).2026.5313

Keywords:

Preterm Infants, Human Milk Fortifiers, HMBF, BMBF, Necrotizing Enterocolitis, Growth

Abstract

Background: Preterm infants, particularly those with very low birth weight (VLBW) and extremely low birth weight (ELBW), have substantially increased nutritional requirements. Although human milk provides many protective benefits, it does not fully meet the nutritional needs of this population, which justifies the routine use of human milk fortifiers. Traditionally used bovine milk–based fortifiers (BMBF) have raised concerns regarding their potential association with necrotizing enterocolitis (NEC), which led to the development of human milk–based fortifiers (HMBF).

Objective: This narrative review aimed to present the current state of knowledge regarding the clinical benefits and limitations of HMBF in preterm infants, with particular emphasis on NEC, sepsis, growth, and mortality.

Materials and Methods: A narrative literature review was conducted including randomized controlled trials, observational studies, and systematic reviews and meta-analyses comparing HMBF and BMBF in preterm infants. The analysis focused on clinically relevant outcomes, particularly in ELBW infants and in the context of an exclusive human milk diet.

Results: The reviewed studies indicate a lower incidence of NEC among infants receiving HMBF, particularly within exclusively human milk–based diets. Mortality was also reported to be lower in some cohorts, particularly among ELBW infants. Rates of late-onset sepsis and other major morbidities were generally comparable between groups. Some studies reported slower short-term weight gain with HMBF, whereas long-term growth outcomes showed no consistent differences between feeding strategies.

Conclusions: Current evidence suggests that HMBF may reduce the risk of NEC and mortality in highly vulnerable preterm infants, particularly those with ELBW. Although some studies report slower short-term weight gain, randomized trials have not demonstrated clinically meaningful differences in long-term growth or body composition. Overall, the potential clinical benefits appear to outweigh these temporary differences in growth velocity.

References

World Health Organization. (2023). Preterm birth. https://www.who.int/news-room/fact-sheets/detail/preterm-birth

Walani, S. R. (2020). Global burden of preterm birth. International Journal of Gynecology & Obstetrics, 150(1), 31–33. https://doi.org/10.1002/ijgo.13195

Blencowe, H., Cousens, S., Chou, D., Oestergaard, M., Say, L., Moller, A. B., Kinney, M., & Lawn, J. (2013). Born too soon: The global epidemiology of 15 million preterm births. Reproductive Health, 10(Suppl. 1), Article S2. https://doi.org/10.1186/1742-4755-10-S1-S2

World Health Organization. (2012). Born too soon: The global action report on preterm birth. World Health Organization.

de Paula, I. C. S. F., et al. (2025). Global prevalence of neonatal mortality in preterm infants: A systematic review and meta-analysis. BMC Pregnancy and Childbirth, 25(1), Article 1316. https://doi.org/10.1186/s12884-025-08490-3

Malshe, N. S., et al. (2026). Effect of preterm birth on neonatal, infant, child, young adult and adult mortality: A systematic review and meta-analysis. Journal of Perinatal Medicine. https://doi.org/10.1515/jpm-2025-0474

Brusselaers, N., et al. (2024). Risk of neurodevelopmental impairment in Swedish preterm children treated for necrotizing enterocolitis: Retrospective cohort study. BJS Open, 8(6), Article zrae131. https://doi.org/10.1093/bjsopen/zrae131

Diao, S., et al. (2024). Preterm birth: A neuroinflammatory origin for metabolic diseases? Brain, Behavior, & Immunity – Health, 37, Article 100745. https://doi.org/10.1016/j.bbih.2024.100745

Bavineni, M., et al. (2019). Mechanisms linking preterm birth to onset of cardiovascular disease later in adulthood. European Heart Journal, 40(14), 1107–1112. https://doi.org/10.1093/eurheartj/ehz025

Chehade, H., et al. (2018). Preterm birth: Long-term cardiovascular and renal consequences. Current Pediatric Reviews, 14(4), 219–226. https://doi.org/10.2174/1573396314666180813121652

Arslanoglu, S., et al. (2019). Fortification of human milk for preterm infants: Update and recommendations of the European Milk Bank Association (EMBA) Working Group on Human Milk Fortification. Frontiers in Pediatrics, 7, Article 76. https://doi.org/10.3389/fped.2019.00076

De Curtis, M., & Rigo, J. (2004). Extrauterine growth restriction in very-low-birth-weight infants. Acta Paediatrica, 93(12), 1563–1568. https://doi.org/10.1080/08035250410022198

Hu, F., et al. (2019). Analysis of nutrition support in very low-birth-weight infants with extrauterine growth restriction. Nutrition in Clinical Practice, 34(3), 436–443. https://doi.org/10.1002/ncp.10210

Duerden, E. G., et al. (2021). Early protein intake predicts functional connectivity and neurocognition in preterm born children. Scientific Reports, 11, Article 4085. https://doi.org/10.1038/s41598-021-83125-z

Cabal-Herrera, A., et al. (2025). The impact of undernutrition and overnutrition on early brain development. Seminars in Pediatric Neurology, 55, Article 101212. https://doi.org/10.1016/j.spen.2025.101212

Brown, J. V., Lin, L., et al. (2020). Multi-nutrient fortification of human milk for preterm infants. Cochrane Database of Systematic Reviews, 2020(6), Article CD000343. https://doi.org/10.1002/14651858.CD000343.pub4

Contreras Chova, F., et al. (2024). Strategies for the fortification of human milk in preterm infants: A systematic review. Cureus, 16(11), Article e73380. https://doi.org/10.7759/cureus.73380

Chinnappan, A., et al. (2021). Fortification of breast milk with preterm formula powder vs human milk fortifier in preterm neonates: A randomized noninferiority trial. JAMA Pediatrics, 175(8), 790–796. https://doi.org/10.1001/jamapediatrics.2021.0678

Ananthan, A., et al. (2020). Human milk-derived fortifiers compared with bovine milk-derived fortifiers in preterm infants: A systematic review and meta-analysis. Advances in Nutrition, 11(5), 1325–1333. https://doi.org/10.1093/advances/nmaa039

Aguilar-Lopez, M., et al. (2021). Human milk-based or bovine milk-based fortifiers differentially impact the development of the gut microbiota of preterm infants. Frontiers in Pediatrics, 9, Article 719096. https://doi.org/10.3389/fped.2021.719096

Galis, R., et al. (2024). Association of fortification with human milk versus bovine milk-based fortifiers on short-term outcomes in preterm infants: A meta-analysis. Nutrients, 16(6), Article 910.

Jensen, G. B., et al. (2021). Nordic study on human milk fortification in extremely preterm infants: A randomised controlled trial—the N-forte trial. BMJ Open, 11(11), Article e053400. https://doi.org/10.1136/bmjopen-2021-053400

Assad, M., et al. (2016). Decreased cost and improved feeding tolerance in VLBW infants fed an exclusive human milk diet. Journal of Perinatology, 36(3), 216–220. https://doi.org/10.1038/jp.2015.168

Herrmann, K., & Carroll, K. (2014). An exclusively human milk diet reduces necrotizing enterocolitis. Breastfeeding Medicine, 9(4), 184–190. https://doi.org/10.1089/bfm.2013.0121

Embleton, N. D., et al. (2023). Effect of an exclusive human milk diet on the gut microbiome in preterm infants: A randomized clinical trial. JAMA Network Open, 6(3), Article e231165. https://doi.org/10.1001/jamanetworkopen.2023.1165

Managlia, E., et al. (2022). Intestinal epithelial barrier function and necrotizing enterocolitis. Newborn, 1(1), 32–43. https://doi.org/10.5005/jp-journals-11002-0003

Provitera, L., et al. (2024). Gut microbiota-derived metabolites and their role in the pathogenesis of necrotizing enterocolitis in preterm infants: A narrative review. Metabolites, 14(11), Article 570. https://doi.org/10.3390/metabo14110570

Mihi, B., & Good, M. (2019). Impact of Toll-like receptor 4 signaling in necrotizing enterocolitis: The state of the science. Clinics in Perinatology, 46(1), 145–157. https://doi.org/10.1016/j.clp.2018.09.007

He, Y., et al. (2016). Human milk components modulate Toll-like receptor-mediated inflammation. Advances in Nutrition, 7(1), 102–111. https://doi.org/10.3945/an.115.010090

Carr, L. E., et al. (2021). Role of human milk bioactives on infants’ gut and immune health. Frontiers in Immunology, 12, Article 604080. https://doi.org/10.3389/fimmu.2021.604080

Thai, J. D., & Gregory, K. E. (2020). Bioactive factors in human breast milk attenuate intestinal inflammation during early life. Nutrients, 12(2), Article 581. https://doi.org/10.3390/nu12020581

Gregory, K. E., et al. (2016). Influence of maternal breast milk ingestion on acquisition of the intestinal microbiome in preterm infants. Microbiome, 4(1), Article 68. https://doi.org/10.1186/s40168-016-0214-x

Chen, J., et al. (2025). Impact of mother’s own milk vs donor human milk on gut microbiota colonization in preterm infants: A systematic review. Microbiome Research Reports, 4, Article 8. https://doi.org/10.20517/mrr.2024.44

Gregory, K. E., & Walker, W. A. (2013). Immunologic factors in human milk and disease prevention in the preterm infant. Current Pediatric Reports, 1(4). https://doi.org/10.1007/s40124-013-0028-2

Toth, T., et al. (2025). Risk factors and predictive parameters of necrotizing enterocolitis in preterm infants: A single-center retrospective study. Diseases, 13, Article 368. https://doi.org/10.3390/diseases13110368

Miller, J., et al. (2018). A systematic review and meta-analysis of human milk feeding and morbidity in very low birth weight infants. Nutrients, 10(6), Article 707. https://doi.org/10.3390/nu10060707